<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/300aa–14" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/300aa–14/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/300aa–14/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_300aa_14"><akn:num>300aa–14</akn:num><akn:heading>Vaccine Injury Table</akn:heading><akn:content><akn:p>§ 300aa–14. Vaccine Injury Table(a) Initial tableThe following is a table of vaccines, the injuries, disabilities, illnesses, conditions, and deaths resulting from the administration of such vaccines, and the time period in which the first symptom or manifestation of onset or of the significant aggravation of such injuries, disabilities, illnesses, conditions, and deaths is to occur after vaccine administration for purposes of receiving compensation under the Program:








VACCINE INJURY TABLE






I.DTP; P; DTP/Polio Combination; or Any Other Vaccine Containing Whole Cell Pertussis Bacteria, Extracted or Partial Cell Bacteria, or Specific Pertussis Antigen(s). 
 Illness, disability, injury, or condition covered:Time period for first symptom or manifestation of onset or of significant aggravation after vaccine administration:
 A. Anaphylaxis or anaphylactic shock24 hours
 B. Encephalopathy (or encephalitis) 3 days
 C. Shock-collapse or hypotonic-hyporesponsive collapse 3 days
 D. Residual seizure disorder in accordance with subsection (b)(2) 3 days
 E. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribedNot applicable
II.Measles, mumps, rubella, or any vaccine containing any of the foregoing as a component; DT; Td; or Tetanus Toxoid. 
 A. Anaphylaxis or anaphylactic shock24 hours
 B. Encephalopathy (or encephalitis)15 days (for mumps, rubella, measles, or any vaccine containing any of the foregoing as a component). 3 days (for DT, Td, or tetanus toxoid).
 C. Residual seizure disorder in accordance with subsection (b)(2)15 days (for mumps, rubella, measles, or any vaccine containing any of the foregoing as a component). 3 days (for DT, Td, or tetanus toxoid).
 D. Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury,</akn:p></akn:content><akn:subsection eId="subsec_300aa_14_a"><akn:num>(a)</akn:num><akn:heading>Initial table</akn:heading><akn:content><akn:p>(a) Initial table The following is a table of vaccines, the injuries, disabilities, illnesses, conditions, and deaths resulting from the administration of such vaccines, and the time period in which the first symptom or manifestation of onset or of the significant aggravation of such injuries, disabilities, illnesses, conditions, and deaths is to occur after vaccine administration for purposes of receiving compensation under the Program:








VACCINE INJURY TABLE






I.DTP; P; DTP/Polio Combination; or Any Other Vaccine Containing Whole Cell Pertussis Bacteria, Extracted or Partial Cell Bacteria, or Specific Pertussis Antigen(s). 
 Illness, disability, injury, or condition covered:Time period for first symptom or manifestation of onset or of significant aggravation after vaccine administration:
 A. Anaphylaxis or anaphylactic shock24 hours
 B. Encephalopathy (or encephalitis) 3 days
 C. Shock-collapse or hypotonic-hyporesponsive collapse 3 days
 D. Residual seizure disorder in acc</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_300aa_14_b"><akn:num>(b)</akn:num><akn:heading>Qualifications and aids to interpretation</akn:heading><akn:content><akn:p>(b) Qualifications and aids to interpretation The following qualifications and aids to interpretation shall apply to the Vaccine Injury Table in subsection (a):</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_300aa_14_c"><akn:num>(c)</akn:num><akn:heading>Administrative revision of table</akn:heading><akn:content><akn:p>(c) Administrative revision of table</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_300aa_14_d"><akn:num>(d)</akn:num><akn:heading>Role of Commission</akn:heading><akn:content><akn:p>(d) Role of Commission Except with respect to a regulation recommended by the Advisory Commission on Childhood Vaccines, the Secretary may not propose a regulation under subsection (c) or any revision thereof, unless the Secretary has first provided to the Commission a copy of the proposed regulation or revision, requested recommendations and comments by the Commission, and afforded the Commission at least 90 days to make such recommendations.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_300aa_14_e"><akn:num>(e)</akn:num><akn:heading>Additional vaccines</akn:heading><akn:content><akn:p>(e) Additional vaccines</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>